FDA Approves First New Major Depression Drug in Decades

The U.S. Food and Drug Administration this week approved a rapid-acting antidepressant nasal spray. Spravato (esketamine), in conjunction with an oral antidepressant, is targeted at adults with major depressive disorder who have not […]
The post FDA Approves First New Major Depression Drug in Decades appeared first on Geek.com.